Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement re Issue of Equity

4 Jul 2014 16:32

RNS Number : 5460L
Maven Income & Growth VCT 4 PLC
04 July 2014
 

Maven Income and Growth VCT 4 PLC

 

Issue of Equity and Total Voting Rights - Replacement

 

The issuer advises that the following replaces the Maven Income and Growth VCT 4 PLC - Issue of Equity and Total Voting Rights announcement released at 09.50 BST on 2 July 2014.

 

At the end of the third paragraph in the announcement the number of Ordinary Shares allotted pursuant to the Offer and the number of additional Ordinary Shares allotted have now been identified separately, and the date on which dealings in shares is expected to commence has been revised to "on or around 8 July 2014".

 

The reference to the date of the announcement by the Board (of the postponement of the allotment of Ordinary Shares) has been corrected to state 30 April 2014.

 

All other details remain unchanged.

 

The full amended version is shown below.

 

On 24 October 2013, Maven Income and Growth VCT 4 plc (the "Company"), Maven Income and Growth VCT plc, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to £20 million (before issue costs) together with an over-allotment facility for up to a further £5 million, in aggregate (the "Offer").

 

In view of discussions between the VCT industry and HM Treasury regarding proposed changes to regulations contained in The Finance Bill 2014, which would have applied to VCT shares issued on or after 6 April 2014, the Company announced on 30 April 2014 that the Directors of the Company proposed to postpone the allotment of new Ordinary Shares under the Offer for the 2014/15 tax year until the Directors believed that there was certainty that allotments could take place without contravening the new rules. HM Treasury has clarified the operation of these new regulations to the Board's satisfaction and, on 28 May 2014, the Board announced that the Offer would close at 5.00 pm on 30 May 2014 unless fully subscribed by an earlier date, with the allotment and listing of the new Ordinary Shares occurring as soon as practicable thereafter. 

 

The Board now confirms that all valid applications in respect of the 2014/15 tax year have been accepted in full and in relation to the applications received the Company issued and allotted a further 548,108 Ordinary Shares of 10 pence each on 1 July 2014 at an offer price of 99.07p per Ordinary Share (533,929 of which were allotted to applicants pursuant the Offer and a further 14,179 of which were allotted to the same persons at the same offer price as a result of the delay in allotting those shares pursuant the Offer).

 

As a result of the further allotment the number of Ordinary Shares now in issue is 29,406,381, and the total voting rights of the Company, is 33,270,257.

 

Dealings in all the Ordinary Shares allotted are now expected to commence on or around 8 July 2014.

 

Since the publication of the Prospectus, in aggregate, 4,273,209 Ordinary Shares of 10 pence each have been issued by the Company in relation to the Offer, with net proceeds of £4.09 million being raised by the Company through the issue of those shares.

 

For further information please contact Maven Capital Partners UK LLP by telephone on 0141 306 7400 or by e-mail to enquiries@mavencp.com.

 

Maven Capital Partners UK LLP

Secretary

 

4 July 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESSEFILFLSEDW
Date   Source Headline
9th May 20242:35 pmRNSResult of AGM
9th May 20242:28 pmRNSUnaudited Net Asset Value
1st May 202410:08 amRNSIssue of Equity
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:48 pmRNSIssue of Equity
27th Mar 202410:39 amRNSIssue of Equity
25th Mar 202410:14 amRNSStatement re Offer for Subscription
19th Mar 20245:03 pmRNSTransaction in Own Shares
20th Feb 20242:48 pmRNSDividend Declaration
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:10 amRNSIssue of Equity
17th Jan 202410:03 amRNSDirector/PDMR Shareholding
17th Jan 202410:02 amRNSDirector/PDMR Shareholding
17th Jan 20249:58 amRNSIssue of Equity
15th Jan 20244:28 pmRNSUnaudited Net Value Asset
15th Nov 20235:06 pmRNSTransaction in Own Shares
9th Nov 20233:53 pmRNSNet Asset Value(s)
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.